Latest Strategic Collaborations News

New Zealand Coastal Seafoods (ASX – NZS) marked a key milestone with its MV Bluefin's maiden Coral Sea fishing trip and is advancing plans for a $2 million capital raise amid strategic rebranding.

Optiscan Imaging has entered a three-year strategic collaboration with Australian Clinical Labs to validate and deploy its InForm™ digital pathology platform, aiming to transform diagnostic workflows with real-time tissue analysis.

SSH Group has completed a $2.53 million strategic placement with Xinhai Mining Services, welcoming the global EPC+M+O leader as a 15.5% cornerstone shareholder and setting the stage for accelerated growth.

Archer Materials has partnered with CSIRO to develop cutting-edge quantum machine learning models aimed at revolutionizing fraud detection in financial transactions.

PMET Resources reports a positive feasibility study for its flagship Shaakichiuwaanaan lithium project, revealing a maiden mineral reserve and advancing environmental and exploration milestones.

Caravel Minerals has signed a non-binding MOU with Adani’s Kutch Copper to jointly advance the Caravel Copper Project toward a 2026 Final Investment Decision, exploring funding and offtake agreements.

Tivan Limited has initiated a comprehensive program of works at its recently acquired Molyhil Tungsten-Molybdenum Project, setting the stage for drilling and resource expansion in early 2026.

Marquee Resources has entered a non-exclusive collaboration with Chinese metallurgical leader Yantai Jinao to advance testwork and commercial pathways for its Mount Clement Antimony Project in Western Australia.

Condor Energy has signed a non-binding MoU with Promigas Perú to jointly explore natural gas supply and distribution opportunities from the Piedra Redonda gas field, aiming to unlock value in northern Peru’s energy market.

Immuron Limited has secured FDA approval for its IMM-529 Investigational New Drug application, clearing the way for a Phase 2 clinical trial targeting Clostridioides difficile infection. This milestone marks a significant step forward for a novel oral antibody therapy addressing a critical infectious disease with high recurrence rates.

PEXA Group reported a robust first quarter for FY26, driven by refinancing growth in Australia and rising momentum in the UK market. The company reaffirmed its full-year guidance while advancing key strategic initiatives including platform modernization and a NatWest partnership.

Provaris Energy has advanced its hydrogen and carbon dioxide storage technologies through strategic partnerships and a new Norwegian fabrication facility, setting the stage for commercialisation in European energy markets.